CD200 is a potent new growth factor in Multiple Myeloma dependent on IGF1 receptor signaling
- DOI
- 10.1016/j.tranon.2026.103000
- Published
- 2026-10
- Container
- Translational Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.tranon.2026.103000,
title = {CD200 is a potent new growth factor in Multiple Myeloma dependent on IGF1 receptor signaling},
author = {Angélique Bruyer and Nicolas Robert and Jules Varbedian and Elvira Garcia De Paco and Lauryn Jaffory and Stéphanie Boireau and Christophe Hirtz and Jérôme Vialaret and Pierre Martineau and Bruno Robert and Guilhem Requirand and Guillaume Cartron and Laure Vincent and Charles Herbaux and Jérôme Moreaux and Caroline Bret},
year = {2026},
journal = {Translational Oncology},
doi = {10.1016/j.tranon.2026.103000},
url = {https://doi.org/10.1016/j.tranon.2026.103000}
}RIS
TY - JOUR TI - CD200 is a potent new growth factor in Multiple Myeloma dependent on IGF1 receptor signaling AU - Angélique Bruyer AU - Nicolas Robert AU - Jules Varbedian AU - Elvira Garcia De Paco AU - Lauryn Jaffory AU - Stéphanie Boireau AU - Christophe Hirtz AU - Jérôme Vialaret AU - Pierre Martineau AU - Bruno Robert AU - Guilhem Requirand AU - Guillaume Cartron AU - Laure Vincent AU - Charles Herbaux AU - Jérôme Moreaux AU - Caroline Bret PY - 2026 JO - Translational Oncology DO - 10.1016/j.tranon.2026.103000 UR - https://doi.org/10.1016/j.tranon.2026.103000 ER -
APA
Bruyer, A., Robert, N., Varbedian, J., Paco, E. G. D., Jaffory, L., Boireau, S., Hirtz, C., Vialaret, J., Martineau, P., Robert, B., Requirand, G., Cartron, G., Vincent, L., Herbaux, C., Moreaux, J., & Bret, C. (2026). CD200 is a potent new growth factor in Multiple Myeloma dependent on IGF1 receptor signaling. Translational Oncology. https://doi.org/10.1016/j.tranon.2026.103000
Source records
- crossref · retrieved 2026-09-27T02:14:36.273Z